Vimta Labs (BOM:524394) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524394 Vimta Labs Ltd BOM:524394
85 GF Score
Price ₹615.30
GF Value ₹510.42
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Vimta Labs Other Current Receivables?

Vimta Labs BOM:524394 -2.41% 85 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:524394 with a GF Score™ of 85/100 and a GF Value™ of ₹510.42 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Vimta Labs's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Vimta Labs's annual Other Current Receivables increased from Mar. 2024 (₹2.63 Mil) to Mar. 2025 (₹5.03 Mil) and increased from Mar. 2025 (₹5.03 Mil) to Mar. 2026 (₹11.76 Mil).

Vimta Labs Other Current Receivables Related Terms

Vimta Labs Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Vimta Labs's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimta Labs Other Current Receivables Chart

Vimta Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 4.25 2.63 5.03 11.76

Vimta Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.93 0.00 11.76 0.00
BOM:524394
85GF Score
Vimta Labs Ltd BOM:524394
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimta Labs Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
Vimta Labs (BOM:524394) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Vimta Labs and its competitors.
Is Vimta Labs' Other Current Receivables too high?
Vimta Labs' current Other Current Receivables is ₹0 Mil. Overall, Vimta Labs has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vimta Labs' Other Current Receivables compare to TMO and DHR?
Vimta Labs' Other Current Receivables of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Diagnostics & Research company?
A good Other Current Receivables depends on the Medical Diagnostics & Research industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Vimta Labs and its competitors. Vimta Labs's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimta Labs stock overvalued right now?
Based on GuruFocus' analysis, Vimta Labs (BOM:524394) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹510.42, compared to a current price of ₹615.30 — trading 20.5% above its estimated fair value. The current Other Current Receivables is ₹0 Mil. Vimta Labs' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Vimta Labs (BOM:524394), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimta Labs (BOM:524394) Overvalued in 2026?

Based on GuruFocus' analysis, Vimta Labs stock appears to be overvalued. The current stock price of ₹615.30 is trading 20.5% above its estimated GF Value™ of ₹510.42. GuruFocus considers Vimta Labs to be Modestly Overvalued.

Key valuation signals for BOM:524394:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹510.42 vs. price of ₹615.30 (20.5% above fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the BOM:524394 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimta Labs Business Description

Other Exchanges VIMTALABS:India
Address Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.
85GF Score

Get the complete analysis for BOM:524394

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹615.30
Price
₹510.42
GF Value